Most people asking about prevention are asking one question in three different ways: what really works, what is worth my money, and what is a waste of time. After two decades of practicing medicine, here is the honest map.
Prevention runs on three levers — medications, food and dietary pattern, and supplements. Those levers are not equal. Across nearly every organ system, guideline-directed medication and a sustained healthy dietary pattern carry the strongest outcome evidence. Supplements are a much narrower story: a few have a real signal, many are neutral, and a handful cause harm.
Root cause matters. So does what the trials actually show. Both can be true, and at Integrative Medical Partners we work from both.
The short version
- Strongest evidence: not smoking, weight and metabolic control, blood pressure and lipid control, physical activity, treating infections that drive cancer (HPV, hepatitis B and C), limiting alcohol, and a predominantly whole-food, plant-forward dietary pattern.
- Real but targeted: specific medications in specific risk groups — statins, blood pressure therapy, SGLT2 inhibitors, GLP-1 receptor agonists, RAS inhibitors, and risk-reducing endocrine therapy for elevated breast cancer risk.
- Weak or unproven: the majority of supplements marketed for organ “protection.”
- Potentially harmful: beta-carotene (especially in smokers), high-dose vitamin A and E, and high-dose supplemental calcium.
Heart and vascular prevention
Cardiovascular disease prevention rests on three complementary pillars: proven medication, a heart-healthy dietary pattern, and — for supplements — a much narrower evidence base.
Medications with outcome evidence
- Statins — the foundation of both primary and secondary prevention, with reductions in cardiovascular mortality, all-cause mortality, and major events. The 2026 ACC/AHA dyslipidemia guideline recommends starting lipid-lowering therapy at a 10-year PREVENT-ASCVD risk of 5% or higher, with an LDL-C goal under 70 mg/dL in high-risk individuals.
- Ezetimibe — a reasonable add-on to reach LDL goals, with tolerability comparable to statin monotherapy.
- Bempedoic acid — reduces major cardiovascular events, including in high-risk primary prevention patients who cannot tolerate statins.
- PCSK9 inhibitors — reduce events in established cardiovascular disease.
- Blood pressure therapy — decades of evidence, with additional benefit from intensive control.
- Aspirin — helps in selected patients, but must always be weighed against bleeding risk. This is an individual conversation, not a default.
- SGLT2 inhibitors and GLP-1 receptor agonists — reduce major cardiovascular events and all-cause mortality.
Food
Dietary pattern, not isolated nutrients, is the cornerstone. Emphasize a variety of fruits and vegetables, whole grains, legumes, nuts and seeds, fish and seafood, low-fat dairy, and liquid non-tropical plant oils such as olive, canola, and sunflower. Limit saturated and trans fats, refined carbohydrates and added sugar, sugar-sweetened beverages, sodium, ultra-processed foods, and processed red meat.
The Mediterranean, DASH, Healthy US-Style, and healthy vegetarian patterns are all associated with 14% to 28% lower cardiovascular mortality. There is not yet sufficient evidence to endorse ketogenic diets or intermittent fasting for cardiovascular prevention. On alcohol: if you do not drink, do not start.
Supplements
Most products marketed “for heart health” have not reduced clinical events. Omega-3, folate, and CoQ10 carry the most favorable — though limited-certainty — data. Beta-carotene and calcium plus vitamin D may cause harm. None of these substitute for proven therapy. We do not publish supplement doses here, because the right one depends on your labs and your medication list.
Metabolic health, weight, and GLP-1 medications
Weight and metabolic control sit upstream of almost everything else on this page — heart, kidney, liver, joints, and several cancers all track with it. That is why metabolic care is the highest-leverage prevention work most people can do.
GLP-1 receptor agonists now have robust, consistent evidence for reducing major adverse cardiovascular events, and that benefit has been extended beyond type 2 diabetes to people with overweight or obesity without diabetes. Pooled trial data show roughly a 14% relative reduction in three-point MACE, with parallel reductions in heart failure hospitalization, kidney outcomes, and all-cause mortality.
Read the full GLP-1 cardiovascular risk reduction page →
Kidney prevention
This is one area where the pharmaceutical evidence is decisively stronger than the natural one. No supplement has trial-quality proof of kidney protection.
- RAS inhibitors (ACE inhibitors or ARBs) — first-line for chronic kidney disease with diabetes, and for non-diabetic kidney disease with protein in the urine. Single agent only; dual blockade adds risk without benefit.
- SGLT2 inhibitors — reduce kidney failure risk by roughly one-third and heart failure by roughly two-fifths, with benefit regardless of diabetes status.
- Finerenone — reduces kidney progression and cardiovascular events in type 2 diabetes with kidney disease; potassium must be monitored.
- Statins and, where diabetes coexists, GLP-1 receptor agonists — layered on top based on individual risk.
On the lifestyle side: healthy diet, physical activity, weight management, smoking cessation, and moderated protein intake in line with KDIGO guidance. Curcumin, quercetin, resveratrol, garlic, and green tea catechins look promising in animal models, but human trials are scarce. Some botanicals are outright nephrotoxic — aristolochic acid–containing herbs are the classic example. If you have kidney disease, every supplement you take deserves review.
Liver prevention
Liver prevention starts by treating the cause. Suppressing hepatitis B and curing hepatitis C are among the most effective ways to prevent cirrhosis and liver cancer, and hepatitis B vaccination lowers that risk further.
- Alcohol — abstinence reduces mortality in alcohol-related liver disease. With significant fibrosis of any cause, complete abstinence is the recommendation.
- Weight loss and diet — a calorie-deficit Mediterranean-style pattern plus increased activity is first-line for fatty liver disease.
- Coffee — three or more cups daily, caffeinated or decaf, is associated with less advanced liver disease and lower liver cancer risk. Go easy on the cream and sugar.
- Medications with liver-specific benefit — resmetirom and semaglutide are now FDA-approved for non-cirrhotic MASH with F2–F3 fibrosis; pioglitazone and vitamin E are off-label options in selected patients, each with real trade-offs.
Worth knowing: milk thistle (silymarin) is the most popular liver supplement in America, and it is explicitly listed among agents that do not provide meaningful tissue-level benefit in MASH. Several natural products lower liver enzymes on a lab report without changing the disease underneath. Numbers moving is not the same as disease reversing.
Digestive prevention
In gut health, diet has moved from side advice to primary therapy.
- Low-FODMAP — the best-evidenced dietary therapy for IBS, done properly in three phases: restriction, reintroduction, then personalization. It is not meant to be permanent.
- Mediterranean pattern — recommended for inflammatory bowel disease patients absent a contraindication. Note honestly: no diet has consistently reduced IBD flare rates, though lower red and processed meat may lower ulcerative colitis flares.
- Crohn’s Disease Exclusion Diet with partial enteral nutrition — the strongest mucosal-healing data in active Crohn’s.
- Celiac disease — a strict lifelong gluten-free diet remains primary. Gluten avoidance is not advised in IBD without celiac disease or documented sensitivity.
On supplements: curcumin combined with 5-ASA has the most consistent randomized evidence for mild-to-moderate ulcerative colitis. Peppermint oil has demonstrated antispasmodic benefit in IBS. Probiotics show variable success with low risk of harm, limited mostly by inconsistent strains and dosing. If you are managing IBD, our Crohn’s and IBD integrative care page goes deeper.
Joint prevention
There is no proven “chondroprotective” drug that reliably prevents osteoarthritis. Prevention here is lifestyle-driven, and the effect sizes are not small.
- Weight loss — the single most impactful modifiable factor. Diet plus exercise outperforms either alone.
- Exercise — supervised, unsupervised, and aquatic programs all improve pain and function, with effect sizes comparable to or larger than medication.
- Diet — reduced-energy diets show the strongest signal; prudent, anti-inflammatory, higher-fiber patterns are associated with slower progression, while a Western pattern accelerates it.
- Medications — topical NSAIDs first, then oral NSAIDs short-term, duloxetine in selected patients, and intra-articular steroids for short-term relief. These control symptoms; they do not prevent the disease. Opioids and tramadol are avoided.
- Supplements — turmeric, ginger extract, glucosamine, chondroitin, and vitamin D carry a limited-strength recommendation for mild-to-moderate knee OA. Benefit is modest and inconsistent; risk is mainly cost.
Cancer prevention
Roughly 30% to 50% of cancers are attributable to modifiable factors. In the United States, smoking, excess body weight, and alcohol lead the list.
- Pattern over pills — the American Cancer Society, WCRF/AICR, and the European Code Against Cancer converge on the same picture: predominantly plant-based, higher in fish and unsaturated fats, low in red and processed meat, added sugar, ultra-processed food, and alcohol.
- Colorectal cancer has the most consistent diet signal of any site.
- Alcohol raises risk of breast, colorectal, esophageal, liver, and head and neck cancers with no established safe threshold.
- Infection control — HPV and hepatitis B vaccination prevent cancers outright.
- Preventive medication — for women at elevated breast cancer risk, tamoxifen, raloxifene, and aromatase inhibitors reduce estrogen-receptor-positive breast cancer meaningfully. Eligibility is specific: age 35 or older with a 5-year Gail risk of 1.7% or higher, a 10-year IBIS risk of 5% or higher, or a history of LCIS. Tamoxifen is the only option before menopause.
The consistent message from USPSTF, ACS, WCRF/AICR, and NCCN is that supplements are not recommended for cancer prevention and nutrients should come from food. Beta-carotene increases lung cancer risk, particularly in smokers. High-dose vitamins A and E have been linked to serious harms. Vitamin D did not reduce cancer incidence in the VITAL trial, though a mortality signal emerged.
Mood and brain
Prevention is not only physical. Depression is one of the most under-treated drivers of poor health outcomes, and the evidence for a combined approach — medication where indicated, plus exercise, diet, and select nutraceuticals — is strong.
If you are in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency department.
Read the full depression page → · The 14 modifiable dementia risk factors →
Supplements: the honest scorecard
| Category | Examples | Where the evidence stands |
|---|---|---|
| Some signal | Omega-3 (EPA-predominant), folate, CoQ10, curcumin, vitamin D, probiotics | Reasonable adjuncts, generally limited-certainty evidence |
| Largely neutral | Multivitamins, glucosamine and chondroitin, silymarin for liver disease, omega-3 for cancer prevention | Low risk, low or unproven benefit |
| Potential harm | Beta-carotene, high-dose vitamins A and E, high-dose supplemental calcium, aristolochic acid herbs | Associated with increased risk in trials or observational data |
Supplements are also less rigorously regulated than FDA-approved medication. Quality and purity vary between brands, which is exactly why anything we recommend is individualized and provided through our office rather than picked off a shelf. See also: do I need a multivitamin?
How we approach prevention here
What works for the patient is what is right. Natural and pharmaceutical options both have a place, and pretending otherwise does not serve anyone. Our work is to find the cause, use the tool that fits the person in front of us, and remove the things that are not earning their keep.
That usually looks like a real conversation, comprehensive labs, and a plan you can actually live inside — hormone optimization, metabolic and GLP-1 support, targeted nutrition, and the medications that carry outcome evidence for your specific risk.
If anything was possible regarding your health, what would you want?
Text us at 480-485-2197 to schedule, or call. Quick response, real scheduling, no phone tree.
To Health and Wellness,
Dr. Tallman
Frequently asked questions
Can supplements replace prescription medication for prevention?
No. Across cardiovascular, kidney, liver, and cancer prevention, guidelines consistently note that supplements have not shown the outcome benefit that guideline-directed medication has. Supplements are best understood as adjuncts, and some carry real risk.
What is the single highest-impact prevention step?
For most adults, it is metabolic health — weight, blood sugar, blood pressure, and lipids — followed closely by not smoking and limiting alcohol. Those factors move risk across nearly every organ system at once.
Is there a diet that prevents disease across the board?
The closest thing is a Mediterranean-style pattern: plant-forward, whole grains, legumes, nuts, fish, olive oil, minimal ultra-processed food and added sugar. It shows benefit in cardiovascular, liver, gut, cancer, and mood outcomes.
Are any supplements actually dangerous?
Yes. Beta-carotene increases lung cancer risk, particularly in smokers. High-dose vitamin E has been linked to hemorrhagic stroke. High-dose supplemental calcium is associated with higher prostate cancer risk. Certain herbs are directly toxic to the kidneys. This is a conversation to have with a physician who knows your labs and your medication list.
How do I know which prevention strategy applies to me?
Risk is individual. The right plan depends on your labs, your family history, your current medications, and what you are willing to sustain. That is the conversation to have with a physician who will look at all of it.
Integrative Medical Partners
1910 S Stapley Dr #120, Mesa, AZ 85204
480-485-2197
This page is educational and reflects published clinical evidence as of 2026. It is not medical advice and does not establish a physician-patient relationship. No dosages are published here; individual risk, medication decisions, and supplement use are reviewed individually through our office. If you are in crisis, call or text 988.